{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:25:56Z","timestamp":1775600756995,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jep.2007.11.027","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T15:31:02Z","timestamp":1196177462000},"page":"167-172","source":"Crossref","is-referenced-by-count":28,"title":["Therapeutic effects and mechanisms of total flavonoids of Turpinia Arguta Seen on adjuvant arthritis in rats"],"prefix":"10.1016","volume":"116","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Chun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong-Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2007.11.027_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.1780330302","article-title":"Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2007.11.027_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0049-0172(96)80041-2","article-title":"Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis","volume":"26","author":"Badolato","year":"1996","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2007.11.027_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3181\/00379727-145-37863","article-title":"Adjuvant disease in rats: biochemical criteria for distinguishing several phases of inflammation and arthritis","volume":"145","author":"Baimgartner","year":"1974","journal-title":"Proceedings in Society of Experimental Biological Medicine"},{"key":"10.1016\/j.jep.2007.11.027_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.1780340908","article-title":"Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis","volume":"34","author":"Chu","year":"1991","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2007.11.027_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.berh.2003.09.009","article-title":"The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases","volume":"18","author":"Dayer","year":"2004","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"key":"10.1016\/j.jep.2007.11.027_bib6","first-page":"133","article-title":"Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases","volume":"4","author":"Dinarello","year":"1992","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.jep.2007.11.027_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2249.2003.02167.x","article-title":"Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis","volume":"132","author":"Ding","year":"2003","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.jep.2007.11.027_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jep.2007.11.027_bib9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jep.2007.11.027_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2249.2005.02744.x","article-title":"New therapies for rheumatoid arthritis","volume":"140","author":"Goldblatt","year":"2005","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.jep.2007.11.027_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/ACPJC-2004-141-3-069","article-title":"Combination disease-modifying antirheumatic drug therapy reduced work disability in early rheumatoid arthritis","volume":"141","author":"Hunter","year":"2004","journal-title":"ACP Journal Club"},{"key":"10.1016\/j.jep.2007.11.027_bib12","first-page":"62","article-title":"Therapeutic action of leflunomide on adjuvant arthritis rats and its mechanism","volume":"17","author":"Jin","year":"2001","journal-title":"Chinese Pharmacological Bulletin"},{"key":"10.1016\/j.jep.2007.11.027_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","article-title":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation","volume":"11","author":"Kotake","year":"1996","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.jep.2007.11.027_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1568008053174741","article-title":"Signal transduction by IL-2 and its receptors as target in treatment of rheumatoid arthritis.","volume":"5","author":"Kozanidou","year":"2005","journal-title":"Current Drug Targets. Immune, Endocrine and Metabolic Disorders"},{"key":"10.1016\/j.jep.2007.11.027_bib15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2007.11.027_bib16","first-page":"467","article-title":"The determination of flavonoid content of flowers of Chrysanthemum indicum","volume":"22","author":"Lin","year":"2002","journal-title":"Guihaia"},{"key":"10.1016\/j.jep.2007.11.027_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0162-3109(96)00110-5","article-title":"Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603","volume":"34","author":"Ohta","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jep.2007.11.027_bib18","first-page":"95","article-title":"Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study","volume":"142","author":"Pelletier","year":"1993","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.jep.2007.11.027_bib19","first-page":"R1550","article-title":"Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats","volume":"273","author":"Philippe","year":"1997","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.jep.2007.11.027_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.184.3.883","article-title":"Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo","volume":"184","author":"Portanova","year":"1996","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.jep.2007.11.027_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.167.1.469","article-title":"Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells.","volume":"167","author":"Stichtenoth","year":"2001","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jep.2007.11.027_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0033-8389(03)00167-2","article-title":"Advanced imaging of early rheumatoid arthritis","volume":"42","author":"Tehranzadeh","year":"2004","journal-title":"Radiologic Clinics of North America"},{"key":"10.1016\/j.jep.2007.11.027_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-2952(01)00654-2","article-title":"Major roles of prostanoid receptors IP and EP (3) in endotoxin-induced enhancement of pain perception","volume":"62","author":"Ueno","year":"2001","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jep.2007.11.027_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4899-1810-9_27","article-title":"Mechanism of action of anti-inflammatory drugs","volume":"433","author":"Vane","year":"1997","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.jep.2007.11.027_bib25","first-page":"223","article-title":"Adjuvant-induced arthritis in rats. II. Drug effects on physiologic biochemical and immunologic parameters","volume":"178","author":"Walz","year":"1971","journal-title":"Journal of Pharmacology Experiment and Therapeutics"},{"key":"10.1016\/j.jep.2007.11.027_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/3-540-26811-1_5","article-title":"Models of rheumatoid arthritis","author":"Williams","year":"2005","journal-title":"Ernst Schering Research Foundation Workshop"},{"key":"10.1016\/j.jep.2007.11.027_bib27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3","article-title":"Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis","volume":"42","author":"Yang","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jep.2007.11.027_bib28","series-title":"Experimental Methods of Pharmacology","first-page":"723","article-title":"Methods of the experimental study on immunomodulatory inflammatory","author":"Yu","year":"1991"},{"key":"10.1016\/j.jep.2007.11.027_bib29","first-page":"185","article-title":"Anti-inflammatory activity of TFS in experimental models","volume":"38","author":"Zhang","year":"2003","journal-title":"Acta Universitatis Medicinalis Anhui"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874107006071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874107006071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:02:47Z","timestamp":1684108967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874107006071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0378874107006071"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2007.11.027","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}